Phase II Double Blind Placebo Controlled Trial of Risperidone in Tourette Syndrome

Clinical trial NCT00004393 · COMPLETED

Trial details

NCT number: NCT00004393
Sponsor: National Center for Research Resources (NCRR)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Tourette Syndrome

Start date: 1997-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.